ArticleCancer chemotherapy and pharmacology2015

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine.

Edward M Newman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.